Delivery Order SPE2DB22D1017-SPE2DB25FG9PY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valsartan 320 mg tablets (90-count) with a ceiling value of $1,165.45. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count units) with a ceiling value of $2,651.15. This delivery order, issued under firm fixed-price terms with no set-aside designation, represents a competitively awarded procurement from AmerisourceBergen's existing indefinite delivery contract vehicle with the DLA. The product will be performed at the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a quantity of 90 units, with a contract ceiling value of $4,211.74. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for ultimate completion by August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,607.52 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count). This competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of July 28, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $36,196.14 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procedures and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,356.18 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) valued at $5,573.64. This is a firm fixed-price delivery order with no set-aside designation, and the product is scheduled for delivery by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Valsartan-HCTZ 160-25 mg tablets in quantities of 90 units, with a ceiling value of $3,305.82. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The award was made to AmerisourceBergen Drug Corp at its Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,214.05 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets in a quantity of 90s, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.65 to AmerisourceBergen Drug Corp for 90-count bottles of Valsartan-HCTZ 320-25 mg tablets. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. This delivery order...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9PYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) with a ceiling value of $3,727.23. This is a firm fixed price, non-set-aside delivery order that represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is a child contract action under AmerisourceBergen's comprehensive Indefinite Delivery Contract (SPE2DX) with DLA valued at $999,999,999, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a wide range of pharmaceuticals and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's competitively awarded contract awards demonstrate its capability to fulfill federal medical supply requirements across multiple therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/12/25 |